Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Yinghong Wang, MD,PHD) · ywang59@mdanderson.org · 281-221-9138
Contact: Principal Investigator (Yinghong Wang, MD,PHD)

Study leads

Yinghong Wang, MD,PHD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Breast Cancer · Quality of Life

Abroad (travel likely)RecruitingPHASE2

Chapel Hill, United States

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Breast Cancer Stage I · Breast Cancer Stage II · Breast Cancer Stage III

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States

A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)

Triple-Negative Breast Cancer (TNBC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Shanghai, China